New antibody shot could help protect babies from RSV
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants.
Jun 12, 2025
0
17
Viruses: News and Research on Pneumovirinae
MeSH tree: B04.820.480.937.600.670
hMPV is likely one of the viruses making us sick this season. Here's what to know about human metapneumovirus
As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory illnesses. Most of us are familiar with the usual winter players such as COVID, influenza and RSV ...
Jun 10, 2025
0
15
Odds of cardiovascular events up for RSV hospitalization versus COVID-19 hospitalization
Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations, according to a study published online May 22 in JAMA Network Open.
May 28, 2025
0
16
RSV immunization has saved Australia millions in hospital costs
A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already resulted in 57% lower than expected hospitalizations in WA, saving the health system $6.2–6.9 million, ...
May 27, 2025
0
15
RSV infections in children requiring primary care lead to significant economic impact
Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, according to a study just published ...
May 22, 2025
0
9
US infant mortality dropped in 2024. Experts partly credit RSV shots
The nation's infant mortality rate dropped last year after two years of hovering at a late-pandemic plateau.
May 9, 2025
0
16
72% of infants immunized against respiratory syncytial virus
In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized against respiratory syncytial virus (RSV).
May 6, 2025
0
18
Monoclonal antibody provides strong real-world protection against severe RSV in infants, suggests meta-analysis
Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial virus (RSV) infections in infants, suggests a meta-analysis published in The Lancet Child & Adolescent ...
May 1, 2025
0
43
Timing of RSV immunization matters for infant protection
The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness, according to Yale research published in JAMA Network Open.
Apr 25, 2025
0
47
Children with chronic conditions at risk for severe RSV outcomes, new study finds
Research presented at the Pediatric Academic Societies (PAS) 2025 Meeting, held April 24–28 in Honolulu, reveals that young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus ...
Apr 25, 2025
0
9
